BRPI0409936A - uso de um material, recipiente pelo menos parcialmente cheio, e, kit médico - Google Patents
uso de um material, recipiente pelo menos parcialmente cheio, e, kit médicoInfo
- Publication number
- BRPI0409936A BRPI0409936A BRPI0409936-2A BRPI0409936A BRPI0409936A BR PI0409936 A BRPI0409936 A BR PI0409936A BR PI0409936 A BRPI0409936 A BR PI0409936A BR PI0409936 A BRPI0409936 A BR PI0409936A
- Authority
- BR
- Brazil
- Prior art keywords
- partially filled
- filled container
- medical kit
- wall portion
- coated glass
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F110/00—Homopolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D1/00—Containers having bodies formed in one piece, e.g. by casting metallic material, by moulding plastics, by blowing vitreous material, by throwing ceramic material, by moulding pulped fibrous material, by deep-drawing operations performed on sheet material
- B65D1/02—Bottles or similar containers with necks or like restricted apertures, designed for pouring contents
Abstract
"USO DE UM MATERIAL, RECIPIENTE PELO MENOS PARCIALMENTE CHEIO, E, KIT MéDICO". Um material escolhido do grupo consistindo de: vidro revestido por sílica, vidro revestido por silicone, polímeros de olefinas não cíclicas, polímeros de ciclo-olefinas e copolímeros de ciclo olefina/olefina linear; é vantajoso como um material de parede interna, em um recipiente que é composto de (i) uma porção de parede e (ii) uma ou mais porções de fechamento que não constituem parte da porção da parede, e que contêm uma formulação de uma proteína tendo um dormínio amino-terminal de ácido <sym>-carboxiglutâmico (Gla) com 9-12 resíduos Gla.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200300788 | 2003-05-23 | ||
US47628003P | 2003-06-05 | 2003-06-05 | |
PCT/DK2004/000181 WO2004082708A2 (en) | 2003-03-18 | 2004-03-18 | Liquid, aqueous, pharmaceutical compositions of factor vii polypeptides |
PCT/DK2004/000359 WO2004103398A1 (en) | 2003-05-23 | 2004-05-21 | Protein stabilization in solution |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0409936A true BRPI0409936A (pt) | 2006-04-25 |
Family
ID=34973305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0409936-2A BRPI0409936A (pt) | 2003-05-23 | 2004-05-21 | uso de um material, recipiente pelo menos parcialmente cheio, e, kit médico |
Country Status (13)
Country | Link |
---|---|
US (1) | US8536127B2 (pt) |
EP (1) | EP1628677B1 (pt) |
JP (2) | JP5627832B2 (pt) |
KR (1) | KR20060015574A (pt) |
CN (1) | CN1780638B (pt) |
AT (1) | ATE454900T1 (pt) |
AU (1) | AU2004241698A1 (pt) |
BR (1) | BRPI0409936A (pt) |
CA (1) | CA2525224A1 (pt) |
DE (1) | DE602004025100D1 (pt) |
MX (1) | MXPA05012476A (pt) |
RU (1) | RU2364609C2 (pt) |
WO (1) | WO2004103398A1 (pt) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0215216A (pt) | 2001-12-21 | 2004-11-16 | Novo Nordisk Healthcare Ag | Composição aquosa lìquida, método para preparar uma composição aquosa lìquida de um polipeptìdeo de fator vii, uso de uma composição aquosa lìquida, e, método para o tratamento de uma sìndrome de resposta ao fator vii |
US20040009918A1 (en) * | 2002-05-03 | 2004-01-15 | Hanne Nedergaard | Stabilised solid compositions of modified factor VII |
KR101212025B1 (ko) * | 2002-06-21 | 2013-01-09 | 노보 노르디스크 헬스 케어 악티엔게젤샤프트 | 인자 ⅶ 폴리펩티드의 안정화된 고체 조성물 |
US7897734B2 (en) * | 2003-03-26 | 2011-03-01 | Novo Nordisk Healthcare Ag | Method for the production of proteins |
AU2004241698A1 (en) * | 2003-05-23 | 2004-12-02 | Novo Nordisk Health Care Ag | Protein stabilization in solution |
ATE446768T1 (de) * | 2003-07-01 | 2009-11-15 | Novo Nordisk Healthcare Ag | Flüssige wässrige pharmazeutische zusammnesetzung von factor vii polypeptiden |
EP1656158B1 (en) * | 2003-08-14 | 2016-03-09 | Novo Nordisk Health Care AG | Liquid, aqueous pharmaceutical composition of factor vii polypeptides |
MXPA06006886A (es) * | 2003-12-19 | 2006-09-04 | Novo Nordisk Healthcare Ag | Composiciones estabilizadas de polipeptidos del factor vii. |
US20070041905A1 (en) * | 2005-08-19 | 2007-02-22 | Hoffman Rebecca S | Method of treating depression using a TNF-alpha antibody |
JP2010525034A (ja) * | 2007-05-02 | 2010-07-22 | ノボ ノルディスク ヘルス ケア アーゲー | 芳香族保存料及び抗酸化剤を含有してなる高濃縮第vii因子ポリペプチド製剤 |
CA2685372A1 (en) * | 2007-05-02 | 2008-11-13 | F. Hoffmann-La Roche Ag | Method for stabilizing a protein |
EP2237038B1 (en) * | 2007-10-22 | 2015-04-29 | Becton Dickinson and Company | Medical articles coated with organopolysiloxane containing a protein solution and non-ionic surfactant |
KR20190045414A (ko) * | 2007-11-30 | 2019-05-02 | 애브비 바이오테크놀로지 리미티드 | 단백질 제형 및 이의 제조방법 |
CN103720587A (zh) * | 2008-02-07 | 2014-04-16 | 安姆根有限公司 | 稳定化的蛋白组合物 |
JP5568551B2 (ja) * | 2008-05-23 | 2014-08-06 | ホスピラ・インコーポレイテツド | 包装済み鉄スクロース製品 |
AU2010202125B1 (en) * | 2010-05-26 | 2010-09-02 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation with improved yield |
KR101634031B1 (ko) * | 2012-05-29 | 2016-06-27 | 벡톤 디킨슨 프랑스 | 윤활제 코팅 및 그러한 코팅을 포함하는 의료용 주사 장치 |
US8883979B2 (en) | 2012-08-31 | 2014-11-11 | Bayer Healthcare Llc | Anti-prolactin receptor antibody formulations |
CN107063940B (zh) | 2016-02-10 | 2019-10-18 | 贝克顿迪金森法国公司 | 用于评价基于蛋白质的制剂的稳定性的方法 |
EP3603602A4 (en) | 2017-03-29 | 2020-08-19 | Terumo Kabushiki Kaisha | PACKAGING FOR PRE-FILLED SYRINGE |
Family Cites Families (90)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US577070A (en) * | 1897-02-16 | Machines | ||
DE2916711A1 (de) * | 1979-04-25 | 1980-11-06 | Behringwerke Ag | Blutgerinnungsfaktoren und verfahren zu ihrer herstellung |
US4956386A (en) * | 1980-04-25 | 1990-09-11 | Gist-Brocades N.V. | Pharmaceutical compositions and process for their preparation |
US4404132A (en) * | 1980-05-27 | 1983-09-13 | Cutter Laboratories, Inc. | Blood coagulation promoting product |
CA1182748A (en) | 1980-11-21 | 1985-02-19 | Gerard Marx | Method for synthesizing procoagulant factor viii activity |
US4495278A (en) * | 1981-04-27 | 1985-01-22 | Baxter Travenol Laboratories, Inc. | Process for making novel blood clotting enzyme compositions |
US4382083A (en) * | 1981-06-25 | 1983-05-03 | Baxter Travenol Laboratories, Inc. | Therapeutic method for treating blood-clotting defects with factor VIIa |
GR860984B (en) * | 1985-04-17 | 1986-08-18 | Zymogenetics Inc | Expression of factor vii and ix activities in mammalian cells |
US5180583A (en) * | 1985-11-26 | 1993-01-19 | Hedner Ulla K E | Method for the treatment of bleeding disorders |
JPH0780783B2 (ja) | 1985-11-26 | 1995-08-30 | ノボ ノルディスク アクティーゼルスカブ | 出血障害の治療のための第▲VII▼a因子を含有する治療組成物 |
US5595886A (en) * | 1986-01-27 | 1997-01-21 | Chiron Corporation | Protein complexes having Factor VIII:C activity and production thereof |
DE3788944T2 (de) | 1986-06-24 | 1994-05-26 | Novo Nordisk As | Verfahren zur herstellung eines koagulationsaktiven komplexes vom faktor viii-fragment. |
DE3877529T2 (de) * | 1987-10-23 | 1996-11-07 | Centre Regional De Transfusion | Herstellung von hoch-gereingtem menschlichen Faktor IX sowie anderem Plasmaproteinkonzentrat und dessen therapeutische Verwendung. |
US5472850A (en) * | 1991-04-10 | 1995-12-05 | Oklahoma Medical Research Foundation | Quantitative clotting assay for activated factor VII |
US5147638A (en) | 1988-12-30 | 1992-09-15 | Oklahoma Medical Research Foundation | Inhibition of tumor growth by blockade of the protein C system |
JP2824430B2 (ja) | 1989-08-02 | 1998-11-11 | 財団法人化学及血清療法研究所 | 血液凝固第▲vii▼因子または活性型血液凝固第▲vii▼因子の調製方法 |
DE3939346A1 (de) | 1989-11-29 | 1991-06-06 | Behringwerke Ag | Arzneimitel zur subkutanen oder intramuskulaeren applikation enthaltend polypeptide |
DE4001451A1 (de) | 1990-01-19 | 1991-08-01 | Octapharma Ag | Stabile injizierbare loesungen von faktor viii und faktor ix |
AU651573B2 (en) * | 1990-01-29 | 1994-07-28 | Novo Nordisk Health Care Ag | Anticoagulant proteins |
US5997864A (en) * | 1995-06-07 | 1999-12-07 | Novo Nordisk A/S | Modified factor VII |
US5833982A (en) | 1991-02-28 | 1998-11-10 | Zymogenetics, Inc. | Modified factor VII |
US5817788A (en) * | 1991-02-28 | 1998-10-06 | Zymogenetics, Inc. | Modified factor VII |
WO1994027631A1 (en) | 1993-05-21 | 1994-12-08 | Zymogenetics, Inc. | Modified factor vii |
US5788965A (en) | 1991-02-28 | 1998-08-04 | Novo Nordisk A/S | Modified factor VII |
CA2103546C (en) | 1991-02-28 | 2002-10-01 | Kathleen L. Berkner | Modified factor vii |
AU2309692A (en) | 1991-07-03 | 1993-02-11 | Cryolife, Inc. | Method for stabilization of biomaterials |
FR2684999A1 (fr) | 1991-12-16 | 1993-06-18 | Aquitaine Dev Transf Sanguine | Procede de fabrication d'un concentre de facteur vii active de haute purete essentiellement depourvu des facteurs vitamine k dependants et des facteurs viiic et viiicag. |
JP3155797B2 (ja) | 1991-12-26 | 2001-04-16 | 株式会社日立製作所 | 過電圧自己保護型半導体装置、及び、それを使用した半導体回路 |
EP0638091B1 (en) * | 1992-04-30 | 2005-12-07 | Probitas Pharma Inc. | Improved solubilization and stabilization of factor viii complex |
ATE197590T1 (de) | 1992-08-27 | 2000-12-15 | Sanquin Bloedvoorziening | Antikoerper spezifisch fur ein haemostatisches protein; seine verwendung zur isolation von intaktem protein; haemostatische zusammensetzungen ohne proteolytische spaltprodukte des proteins |
DK38293D0 (da) * | 1993-03-31 | 1993-03-31 | Novo Nordisk As | Fremstilling af proteiner |
SE9301581D0 (sv) | 1993-05-07 | 1993-05-07 | Kabi Pharmacia Ab | Protein formulation |
AU7254894A (en) * | 1993-07-23 | 1995-02-20 | Baxter International Inc. | Activated human factor viii and method of preparation |
US6277828B1 (en) * | 1993-08-20 | 2001-08-21 | Syntex (U.S.A.) Inc. | Pharmaceutical formulations of nerve growth factor |
US5576291A (en) * | 1993-09-13 | 1996-11-19 | Baxter International Inc. | Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency |
IL113010A0 (en) * | 1994-03-31 | 1995-10-31 | Pharmacia Ab | Pharmaceutical formulation comprising factor VIII or factor ix with an activity of at least 200 IU/ml and an enhancer for improved subcutaneous intramuscular or intradermal administration |
US6372716B1 (en) | 1994-04-26 | 2002-04-16 | Genetics Institute, Inc. | Formulations for factor IX |
DE4435520A1 (de) * | 1994-10-04 | 1996-04-11 | Immuno Ag | Verfahren zur Trennung von rekombinantem pro-Faktor IX von rekombinantem Faktor IX |
SE9403915D0 (sv) * | 1994-11-14 | 1994-11-14 | Annelie Almstedt | Process A |
US5649959A (en) * | 1995-02-10 | 1997-07-22 | Sherwood Medical Company | Assembly for sealing a puncture in a vessel |
DE19531637A1 (de) | 1995-08-28 | 1997-03-06 | Immuno Ag | Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung |
DE19538715A1 (de) | 1995-10-18 | 1997-04-30 | Behringwerke Ag | Verfahren zur Reinigung von Faktor VII und aktiviertem Faktor VII |
SE9503679D0 (sv) | 1995-10-20 | 1995-10-20 | Pharmacia Ab | Antioxidants |
AU7068896A (en) * | 1995-11-09 | 1997-05-15 | Corunum Corporation | Protein composition derived from sesame seed and use thereof |
US5925738A (en) | 1995-12-01 | 1999-07-20 | The American National Red Cross | Methods of production and use of liquid formulations of plasma proteins |
US6320029B1 (en) * | 1996-11-29 | 2001-11-20 | The American National Red Cross | Methods of production and use of liquid formulations of plasma proteins |
US5830852A (en) * | 1995-12-19 | 1998-11-03 | Cobra Therapeutics, Ltd. | Compositions for insulin-receptor mediated nucleic acid delivery |
US5770700A (en) | 1996-01-25 | 1998-06-23 | Genetics Institute, Inc. | Liquid factor IX formulations |
DE19903693A1 (de) | 1998-04-24 | 1999-10-28 | Centeon Pharma Gmbh | Protease zur Aktivierung des Gerinnungsfaktors VII |
TW518219B (en) | 1996-04-26 | 2003-01-21 | Chugai Pharmaceutical Co Ltd | Erythropoietin solution preparation |
AT403989B (de) * | 1996-09-16 | 1998-07-27 | Immuno Ag | Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels |
US6315995B1 (en) | 1996-09-27 | 2001-11-13 | The Trustees Of Columbia University In The City Of New York | Methods for treating an ischemic disorder and improving stroke outcome |
DK0948358T4 (da) | 1996-12-24 | 2012-03-19 | Biogen Idec Inc | Stabile inteferon-væskeformuleringer |
US5804420A (en) | 1997-04-18 | 1998-09-08 | Bayer Corporation | Preparation of recombinant Factor VIII in a protein free medium |
DE19730023A1 (de) | 1997-07-11 | 1999-01-14 | Bayer Ag | Hochreine Ciprofloxacin-Infusion |
US6461610B1 (en) * | 1997-07-18 | 2002-10-08 | Novo Nordisk A/S | Methods for modifying cell motility using factor VIIa or inactivated factor VIIa |
US6310183B1 (en) * | 1997-09-10 | 2001-10-30 | Novo Nordisk A/S | Coagulation factor VIIa composition |
AT409334B (de) | 1997-09-19 | 2002-07-25 | Immuno Ag | Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren |
JPH11335295A (ja) * | 1998-05-22 | 1999-12-07 | Towa Pharmaceutical Co Ltd | カルシウム調節ポリペプチドホルモンの安定な非経口投与用水溶液製剤 |
DE19853033A1 (de) | 1998-11-18 | 2000-05-25 | Centeon Pharma Gmbh | Stabilisierte Proteinzubereitung für einen Gewebekleber |
PT2193809E (pt) * | 1999-02-22 | 2015-08-24 | Baxter Int | Formulações de fator viii livres de albumina |
JP2000247903A (ja) * | 1999-03-01 | 2000-09-12 | Chugai Pharmaceut Co Ltd | 長期安定化製剤 |
US20010031721A1 (en) * | 1999-05-05 | 2001-10-18 | Chandra Webb | Highly concentrated, lyophilized, and liquid factor IX formulations |
JP4674021B2 (ja) * | 1999-07-13 | 2011-04-20 | ビオヴィトルム・アクチボラゲット(プブリクト) | 安定第viii因子組成物 |
DE19937218A1 (de) | 1999-08-06 | 2001-02-08 | Aventis Behring Gmbh | Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Affinitätschromatographie |
US6586574B1 (en) * | 1999-08-17 | 2003-07-01 | Nn A/S | Stabilization of freeze-dried cake |
GB9920758D0 (en) * | 1999-09-03 | 1999-11-03 | Nycomed Amersham Plc | Improved container composition for diagnostic agents |
GB9920772D0 (en) * | 1999-09-03 | 1999-11-03 | Nycomed Amersham Plc | Improved container composition for radiopharmaceutical agents |
US7253142B1 (en) * | 1999-09-08 | 2007-08-07 | Chugai Seiyaku Kabushiki Kaisha | Protein solution preparation and method of stabilizing the same |
US6750053B1 (en) * | 1999-11-15 | 2004-06-15 | I-Stat Corporation | Apparatus and method for assaying coagulation in fluid samples |
DK1257295T3 (da) * | 2000-02-11 | 2009-08-10 | Bayer Healthcare Llc | Faktor VII eller VIIA-lignende molekyler |
US7015194B2 (en) * | 2000-05-10 | 2006-03-21 | Novo Nordisk A/S | Pharmaceutical composition comprising factor VIIa and anti-TFPI |
BR0114373A (pt) * | 2000-10-02 | 2004-02-17 | Novo Nordisk As | Célula hospedeira eucariótica, métodos para a produção de fvii e de fviia ou de suas variantes, de uma proteìna dependente de vitamina k e de uma célula hospedeira eucariótica produtora de fvii ou de seu análogo, vetor recombinante, fvii e fviia recombinante ou suas variantes, e, proteìna dependente de vitamina k recombinante |
WO2002038162A1 (en) * | 2000-11-09 | 2002-05-16 | The Scripps Research Institute | MODIFIED FACTOR VIIa |
DE50114021D1 (de) * | 2001-01-08 | 2008-07-24 | Csl Behring Gmbh | Stabilisierte Flüssigzubereitung der den Blutgerinnungsfaktor VII aktivierenden Protease oder ihres Proenzyms |
US6825323B2 (en) * | 2001-01-10 | 2004-11-30 | The United States Of America As Represented By The Secretary Of The Army | Compositions for treatment of hemorrhaging with activated factor VIIa in combination with fibrinogen and methods of using same |
WO2002065967A1 (en) | 2001-02-20 | 2002-08-29 | Sca Hygiene Products Ab | Diaper cover and method for manufacturing a diaper cover |
US6858587B2 (en) * | 2001-11-02 | 2005-02-22 | Novo Nordisk Pharmaceuticals, Inc. | Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis |
WO2003039585A1 (en) * | 2001-11-09 | 2003-05-15 | Novo Nordisk Health Care Ag | Pharmaceutical composition comprising factor vii polypeptides and protein c inhibitors |
US7078479B2 (en) * | 2001-11-09 | 2006-07-18 | Novo Nordisk Healthcare A/G | Pharmaceutical composition comprising factor VII polypeptides and alpha2-antiplasmin polypeptides |
US7125846B2 (en) * | 2001-11-09 | 2006-10-24 | Novo Nordisk Healthcare A/G | Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides |
US20030119743A1 (en) * | 2001-11-09 | 2003-06-26 | Rasmus Rojkjaer | Pharmaceutical composition comprising factor VII polypeptides and tissue plasminogen inhibitors |
PL370656A1 (en) * | 2001-12-21 | 2005-05-30 | Novo Nordisk A/S | Liquid composition of modified factor vii polypeptides |
BR0215216A (pt) | 2001-12-21 | 2004-11-16 | Novo Nordisk Healthcare Ag | Composição aquosa lìquida, método para preparar uma composição aquosa lìquida de um polipeptìdeo de fator vii, uso de uma composição aquosa lìquida, e, método para o tratamento de uma sìndrome de resposta ao fator vii |
KR20040065278A (ko) * | 2001-12-21 | 2004-07-21 | 노보 노르디스크 에이/에스 | 변경된 인자 ⅶ 폴리펩티드의 액체 조성물 |
US20040009918A1 (en) * | 2002-05-03 | 2004-01-15 | Hanne Nedergaard | Stabilised solid compositions of modified factor VII |
AT501088A2 (de) * | 2002-12-18 | 2006-06-15 | Bio Prod & Bio Eng Ag | Stabile therapeutische proteine |
CA2518327A1 (en) * | 2003-03-18 | 2004-09-30 | Novo Nordisk Health Care Ag | Liquid, aqueous, pharmaceutical compositions of factor vii polypeptides |
US7897734B2 (en) * | 2003-03-26 | 2011-03-01 | Novo Nordisk Healthcare Ag | Method for the production of proteins |
AU2004241698A1 (en) * | 2003-05-23 | 2004-12-02 | Novo Nordisk Health Care Ag | Protein stabilization in solution |
-
2004
- 2004-05-21 AU AU2004241698A patent/AU2004241698A1/en not_active Abandoned
- 2004-05-21 AT AT04734213T patent/ATE454900T1/de not_active IP Right Cessation
- 2004-05-21 CN CN2004800112247A patent/CN1780638B/zh not_active Expired - Fee Related
- 2004-05-21 KR KR1020057020807A patent/KR20060015574A/ko not_active Application Discontinuation
- 2004-05-21 DE DE602004025100T patent/DE602004025100D1/de active Active
- 2004-05-21 JP JP2006529638A patent/JP5627832B2/ja not_active Expired - Fee Related
- 2004-05-21 EP EP04734213A patent/EP1628677B1/en not_active Revoked
- 2004-05-21 WO PCT/DK2004/000359 patent/WO2004103398A1/en active Application Filing
- 2004-05-21 MX MXPA05012476A patent/MXPA05012476A/es unknown
- 2004-05-21 BR BRPI0409936-2A patent/BRPI0409936A/pt not_active IP Right Cessation
- 2004-05-21 RU RU2005140282/04A patent/RU2364609C2/ru active
- 2004-05-21 CA CA002525224A patent/CA2525224A1/en not_active Abandoned
-
2005
- 2005-11-22 US US11/284,709 patent/US8536127B2/en not_active Expired - Fee Related
-
2012
- 2012-06-21 JP JP2012139978A patent/JP2012229230A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US8536127B2 (en) | 2013-09-17 |
ATE454900T1 (de) | 2010-01-15 |
JP2012229230A (ja) | 2012-11-22 |
JP2007502310A (ja) | 2007-02-08 |
RU2005140282A (ru) | 2006-07-27 |
AU2004241698A1 (en) | 2004-12-02 |
EP1628677B1 (en) | 2010-01-13 |
US20060160720A1 (en) | 2006-07-20 |
MXPA05012476A (es) | 2006-02-22 |
CN1780638A (zh) | 2006-05-31 |
KR20060015574A (ko) | 2006-02-17 |
CN1780638B (zh) | 2010-04-14 |
WO2004103398A1 (en) | 2004-12-02 |
RU2364609C2 (ru) | 2009-08-20 |
CA2525224A1 (en) | 2004-12-02 |
DE602004025100D1 (de) | 2010-03-04 |
EP1628677A1 (en) | 2006-03-01 |
JP5627832B2 (ja) | 2014-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0409936A (pt) | uso de um material, recipiente pelo menos parcialmente cheio, e, kit médico | |
CY1108361T1 (el) | ΣΤΑΘΕΡΟ ΣΚΕΥΑΣΜΑ ΠΟΥ ΠΕΡΙΕΧΕΙ TNFR-Fc ΚΑΙ ΑΡΓΙΝΙΝΗ | |
WO2002020069A3 (en) | Antioxidant enriched adhesive compositions and storage containers therefor | |
WO2006083276A3 (en) | Interferon-alpha polypeptides and conjugates | |
DK0713529T3 (da) | Vækst-/differentieringsfaktor af TGF-beta-familien | |
IL185142A0 (en) | Lentiviral packaging constructs | |
NO20031048D0 (no) | "Pseudo"-nativ kjemisk ligering | |
BRPI0407790A (pt) | um kit de limpeza e/ou um kit de lavagem de pratos, contendo um dosador gerador de espuma e uma composição para limpeza e/ou para lavagem de pratos | |
WO2006091972A3 (en) | Dimeric iap inhibitors | |
ES2122520T3 (es) | Composicion de limpieza con dos partes que comprende al menos un compuesto de peroxido. | |
EA200501692A1 (ru) | Жидкие стабилизированные белковые составы в фармацевтических контейнерах с покрытием | |
DE69007662D1 (de) | Verpackung zur Aufnahme und Mischung von zwei Komponenten. | |
AU7861201A (en) | Process of injection moulding a syringe from polythylene wax containing polypropylene, syringe obtained thereby and particulate composition therefor | |
AR033788A1 (es) | Envase primario, uso de un tapon o embolo de caucho que contiene caucho de bromobutilo para sellar el envase primario y procedimiento para la manufactura del envase primario | |
MXPA03008794A (es) | Mejoras en o relacionadas con dispositivos refrescantes de aire. | |
DOP2001000279A (es) | Uso de polimerizados como auxiliares de filtracion y/o estabilizantes. | |
DE60239409D1 (de) | Mehrkammerreagenzbehälter mit mittel zur verhinderung von dessen wiederverwendung | |
ATE206075T1 (de) | Isolierscheiben mit wax enthaltende thermoplastischen adsorptionszusammensetzungen | |
WO2004065410A3 (en) | Mntf peptides and compositions and methods of use | |
WO2007044982A3 (en) | Methods for the preservation of platelet efficacy during storage | |
ATE298784T1 (de) | Wasserlösliche verpackung enthaltend ein mehrphasiges flüssiges waschmittel | |
WO2002022106A3 (en) | Stable ophthalmic preparation | |
BR0209361A (pt) | Dissódio de pamidronato injetável | |
WO2002041823A3 (en) | Transportation of biological specimens | |
ATE342205T1 (de) | Flaschenträger |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012. |